-
Recent Posts
- Babylon Health Applies Artificial Intelligence to Improving Integration of Care and Population Health in Wolverhampton (HTN / RWT / BMJ / Lancet / NHS England)
- Dementia Moonshot Report: Research Priorities and Costs (Alzheimer’s Research UK)
- Dementia-Related Hospital Admissions (BBC News / Alzheimer’s Society)
- NHS Demands Action to Reduce Betting-Related Ill Health (BBC News / NHS England / Respublica)
- Research and Innovation Across the NHS and Academia (BBC News / Academy of Medical Sciences)
Archives
- January 2020
- December 2019
- November 2019
- October 2019
- September 2019
- August 2019
- July 2019
- June 2019
- May 2019
- April 2019
- March 2019
- February 2019
- January 2019
- December 2018
- November 2018
- October 2018
- September 2018
- August 2018
- July 2018
- June 2018
- May 2018
- April 2018
- March 2018
- February 2018
- January 2018
- December 2017
- November 2017
- October 2017
- September 2017
- August 2017
- July 2017
- June 2017
- May 2017
- April 2017
- March 2017
- February 2017
- January 2017
- December 2016
- November 2016
- October 2016
- September 2016
- August 2016
- July 2016
- June 2016
- May 2016
- April 2016
- March 2016
- February 2016
- January 2016
- December 2015
- November 2015
- October 2015
- September 2015
- August 2015
- July 2015
- June 2015
- May 2015
- April 2015
- March 2015
- February 2015
- January 2015
- December 2014
- November 2014
- October 2014
- September 2014
- August 2014
- July 2014
- June 2014
- May 2014
- April 2014
- March 2014
- February 2014
- January 2014
- December 2013
- November 2013
- October 2013
- September 2013
- August 2013
- July 2013
- June 2013
- May 2013
- April 2013
- March 2013
- February 2013
- January 2013
- December 2012
- November 2012
- October 2012
- September 2012
- August 2012
- July 2012
- June 2012
- May 2012
- April 2012
- March 2012
- February 2012
- January 2012
- December 2011
- November 2011
- October 2011
- September 2011
- August 2011
- July 2011
- June 2011
- May 2011
- April 2011
- March 2011
- February 2011
- January 2011
- December 2010
- November 2010
Categories
- Antipsychotics
- Assistive Technology
- Charitable Bodies
- Commissioning
- Delirium
- Depression
- Enhancing the Healing Environment
- Falls
- Falls Prevention
- Guidelines
- Hip Fractures
- Housing
- Hypertension
- In the News
- Integrated Care
- International
- Local Interest
- Mental Health
- Models of Dementia Care
- National
- ADASS
- All-Party Parliamentary Group (APPG) on Dementia
- BSI
- CQC: Care Quality Commission
- Department of Health
- Department of Health and Social Care (DHSC)
- Health Education England (HEE)
- Housing LIN
- MAGDR
- Mental Health Foundation
- Mental Health Network (NHS Confederation)
- MHP Health Mandate
- National Audit Office
- National Voices
- NEoLCIN
- NEoLCP
- NHS
- NHS Alliance
- NHS Confederation
- NHS Employers
- NHS England
- NHS Evidence
- NHS Improvement
- NICE Guidelines
- NIHR
- NIHRSDO
- Northern Ireland
- Patients Association
- Public Health England
- RCN
- Royal College of Physicians
- Royal College of Psychiatrists
- SCIE
- Scotland
- UK
- UK NSC
- Wales
- Non-Pharmacological Treatments
- Nutrition
- Pain
- Parkinson's Disease
- Patient Care Pathway
- Person-Centred Care
- Personalisation
- Pharmacological Treatments
- Proposed for Next Newsletter
- Quick Insights
- Standards
- Statistics
- Stroke
- Systematic Reviews
- Telecare
- Telehealth
- Universal Interest
Google Translate (100+ Languages)
Tag Archives: University of Milan
Funding Initiative (JPco-fuND) for International Dementia Research (MRC)
Summary The EU Joint Programme for Neurodegenerative Disease Research (JPND) has announced €35 million (£25.7 million) funding for research into neurodegenerative diseases. Nine of the 21 research projects involved will benefit UK research teams; these will receive MRC funds through … Continue reading →
Posted in Commissioning, For Doctors (mostly), For Nurses and Therapists (mostly), For Researchers (mostly), International, National, Parkinson's Disease, Quick Insights, UK
|
Tagged 3DMinBrain, 3DPD, Aarhus University, ADAGE: Alzheimer’s Disease Pathology Within the Ageing Physiology., AIT Austrian Institute of Technology Vienna, Animal and Cell Models, aSynProtec: Alpha-Synuclein Pathology Propagation in Parkinson’s Disease and Quest for Novel Protective Strategies., Australia, BRIDGET: Brain Imaging Cognition Dementia and Next Generation GEnomics: a Transdisciplinary Approach to Search for Risk and Protective Factors of Neurodegenerative Disease., Cambridge, Canada, Cardiff, Cardiff University, Centre National de la Recherche Scientifique Bordeaux, Centre National de la Recherche Scientifique Gif sur Yvette, Charité Universitätsmedizin Berlin, CircProt, CNRS Valbonne, Collaboration, Collaboration: Working Across Boundaries, Collaborative Projects, Collaborative Research, Copenhagen University, Cross-Sector Partnerships, CureALS, DACAPO-AD, Dementia Research, Dementia Risk Factors, Deutsches Zentrum für Neurodegenerative Erkrankungen (DZNE) Bonn, Deutsches Zentrum für Neurodegenerative Erkrankungen Tübingen, Dr Rob Buckle: Director of Science Programmes at the Medical Research Council, EADB: A European DNA Bank for Deciphering the Missing Heritability of Alzheimer’s Disease., Edinburgh, EfrAME: Pathway Complexities of Protein Misfolding in Neurodegenerative Diseases: a Novel Approach to Risks Evaluation and Model Development, Environment and Health, EPI-AD: Targeting Epigenetic Dysregulation in the Brainstem in Alzheimer’s Disease., ERA-NET Co-fund, Erasmus MC Rotterdam, Erasmus MC University Medical Center, ESMI: European Spinocerebellar Ataxia Type 3 / Machado-Joseph Disease Initiative., EU Joint Programme in Neurodegenerative Disease (JPND), EU Joint Programme on Neurodegenerative Disease Research (JPND), EU Joint Programme: Neurodegenerative Disease Research (JPND), Europe, European Member States, Faculdade de Ciencias Medicas da Universidade Lisboa, Fondazione IRCCS Istituto Neurologico Carlo Besta Milano, Foundation Carlo Besta Neurological Institute, Funding Alignment of European Member States: Associated Countries: Three Third Countries (Canada Switzerland and Australia), Funding Initiatives, GBA-PARK: GBA1 Mutations in Parkinson Disease: Clinical and Biochemical Prodrome Risk Profile and Pathogenetic Modelling for Therapeutic Intervention., German Center for Neurodegenerative Diseases DZNE Tübingen, Global Challenge of Neurodegenerative Disease, Global Leadership, Global Outlook, H. Lundbeck A/S, Hebrew University of Jerusalem, Heinrich-Heine-University Duesseldorf, Horizon 2020, Hospital Universitari Vall D'Hebron, IGBMC/CNRS/INSERM/Unistra Illkirch, Inserm Lille Hinxton, Inserm U836, Inserm U862, Inserm/UEVE U861 Evry, INSTALZ: Genomic Instability in Alzheimer’s Disease and Related Disorders: a Single-Cell Approach., Institut du Cerveau et de la Moelle Epiniere Paris, Institut Pasteur de Lille, International Collaborations, International Dementia Research, International Partnerships, International Programmes, IRCCS C. Mondino National Neurological Institute, Istituto Nazionale Neurologico Carlo Besta Milan, Joint Transnational Co-Funded Projects in Partnership with European Commission Under ERA-NET Co-fund Scheme, JPco-fuND Initiative, JPcofuND (Funding Programme), JPND Initiative, JPND Research Projects, JPND Research Strategy, JPND Transnational Research, Julius-Maximilians-University of Würzburg, Karolinska Institute Stockholm, Karolinska Institutet, Karolinska Institutet (Stockholm), King’s College, KU Leuven, Laboratory of Molecular Biology (LMB) Neuroscience Division, Lausanne University Hospital (CHUV), Leibniz Institute for Neurobiology, Leuven University, Lifestyle Risk Factors, London, London University College, Longitudinal Cohorts, Lund University, Luxembourg Centre for Systems Biomedicine, MADGIC, Max-Planck-Institute for Molecular Biomedicine Muenster, McGill Genome Center Montréal, Medical Research Council (MRC), Medical Research Council Cambridge, Medical University Graz, Medical University of Greifswald, Misfolded Proteins, ModelPolyQ, NAB3, National Research Council, Neurodegenerative Disease Research, Neurodegenerative Diseases, Neurodegenerative Disorders, Neurodegenerative Research, Overlapping Risk Factors, Oxford, Oxford Parkinson's Disease Centre, Oxford Parkinson's Disease Centre: University of Oxford, Partnership, Partnership and Collaboration, Partnership Working, Professor Philippe Amouyel: Chair of JPND Management Board and Coordinator of JPco-fuND Initiative, PROP-AD, Protein Misfolding, Radboud University Medical Center Nijmegen, REfrAME, Rheinische-Friedrich-Wilhelms-Universität Bonn, Risk and Protective Factors, Risk Factors, Saarland University, Sanger Institute, Sanger Institute-EBI Single-Cell Genomics Centre, Scuola Internazionale Superiore di Studi Avanzati-SISSA Trieste, Slovak Academy of Sciences (SAS) Bratislava, SNOWBALL, STAD, Stichting VU-VUmc Amsterdam, Swiss Federal Institute of Technology Lausanne, Switzerland, SYNACTION, Technion Haifa, Technische Universität Dresden, The Royal Institute of Technology Stockholm, Tissue Disease and Degeneration, Universidade de Lisboa, Universita' degli studi di Milano, Universitaetsklinikum Bonn, Università degli Studi di Modena e Reggio Emilia Modena, Universite D´Artois, University College London, University College London (UCL), University College of London (UCL), University Hospital Cologne, University Hospital of Bonn, University Medical Center Goetingen, University Medical Center Utrecht, University of Bergen, University of Bonn, University of Coimbra, University of Copenhagen, University of Eastern Finland, University of Eastern Finland Kuopio, University of Edinburgh, University of Exeter Medical School, University of Helsinki, University of Mainz, University of Milan, University of Milano, University of New South Wales, University of Ottawa, University of Oxford, University of Tübingen, University of Tel Aviv, University of the Azores Ponta Delgada, University of Toulouse, University of Tuebingen, University of Würzburg, University of Zurich (UZH), Upsalla University, VU University Medical Center
|
Leave a comment
Further Dementia Diagnostic Test Accuracy Systematic Review Protocols (Cochrane Database)
Summary This is an additional list of diagnostic testing-related protocols, further to the Cochrane Dementia and Cognitive Improvement Group (CDCIG) Diagnostic Test Accuracy (DTA) protocols and protocol templates listed earlier in Generic Protocol(s) for Diagnostic Test Accuracy Reviews in Dementia … Continue reading →
Posted in Diagnosis, For Doctors (mostly), For Nurses and Therapists (mostly), For Researchers (mostly), Models of Dementia Care, NIHR, Systematic Reviews, UK
|
Tagged 11C-PIB-PET, 18FDG-PET, 6-Item Cognitive Impairment Test (6-CIT), Abbreviated Mental Test (AMT), Addenbrooke's Cognitive Exaination-Revised (ACE-R), ALOIS: the Cochrane Dementia and Cognitive Improvement Group, APOE e4 (Apolipoprotein E e4), APOE-4 Allele, Asymptomatic Alzheimer’s Disease, Blessed Information-Memory-Concentration Test (Blessed I-M-C), Brain Imaging, Bristol University, Canada, CDCIG: Cochrane Dementia and Cognitive Improvement Group, Central and North West London NHS Foundation Trust, China, China Medical University, Clinical Cooperation Unit Nuclear Medicine (Heidelberg), Clock Drawing Test (CDT), Cochrane Dementia and Cognitive Improvement Group (CDCIG), Cochrane Diagnostic Test Accuracy (DTA) Dementia Reviews, Cochrane Diagnostic Test Accuracy (DTA) Reviews, Cochrane Diagnostic Test Accuracy Review Unit (DTA Unit), Cognitive Assessments / Screening Tools, CSF (Cerebrospinal Fluid Analysis of Amyloid Beta and Tau), CSF Tau, CSF Tau / ABeta Ratio, Department of Neurology: VU University Medical Centre Amsterdam, Devon, Diagnostic Test Accuracy (DTA) Handbook, Diagnostic Test Accuracy Reviews, Differential Diagnosis, Differential Diagnosis of Alzheimer’s Disease, Dopamine Transporter Imaging, Dopamine Transporter Imaging (for Diagnosis of DLB), DTA Handbook, Early Differential Diagnosis, Fondazione I.R.C.C.S. Istituto Neurologico Carlo Besta: Neuroepidemiology Unit, Fondazione IRCCS Istituto Neurologico Carlo Besta, FP-CIT (Fluoropropyl-Carbomethoxy-3b-(4-Iodophenyl)Tropane), Frenchay Hospital (Bristol), Frontotemporal Dementia (FTD), Generic Protocols for Cross-Sectional and Delayed-Verification Studies, German Cancer Research Center: Medical PET Group - Biological Imaging, Germany, Glasgow Royal Infirmary, GP-Cog, Imaging, Imperial College London, Informant Questionnaire on Cognitive Decline in the Elderly (IQCODE), Institute of Cardiovascular and Medical Sciences: Glasgow, Institute of Cardiovascular and Medical Sciences: University of Glasgow, Institute of Health Research: Exeter, Institute of Public Health (Cambridge UK), Institute of Public Health (IPH), Institute of Public Health: Cambridge, IRCCS Fatebenefratelli (Brescia), Italy, John Radcliffe Hospital, LITA Polo Universitario, Maastricht University, Maastricht University: Department of Psychiatry and Neuropsychology, Mini-Cog, Modified Mini-Mental State Examination (3-MS), MRI, MRI Brain Imaging, MRI Scans, National Institute for Health Research (NIHR) Cochrane Collaboration Programme, Netherlands, Neuroimaging in Dementia Diagnosis, Neuropsychological Tests for Alzheimer’s Disease Diagnosis, Neuropsychological Tests for Dementia Diagnosis, North Bristol NHS Trust, Nuffield Department of Clinical Neurosciences (Oxford), Nuffield Department of Clinical Neurosciences: University of Oxford, Nuffield Department of Medicine (Oxford), Older People and Healthy Ageing Service Line (London), OPTIMA (Oxford Project to Investigate Memory and Ageing), OPTIMA (Oxfordshire UK), Ospedale Luigi Sacco, Oxford, Oxford Health NHS Foundation Trust, Oxford University Hospitals NHS Trust, Oxford University Medical School, PenCLAHRC, Peninsula CLAHRC, Peninsula Technology Assessment Group (PenTAG), PET-FDG (Positron Emission Tomography F-Fluorodeoxyglucose), PET-PiB (Positron Emission Tomography-Pittsburgh Compound B), Plasma and Cerebrospinal Fluid (CSF) Abeta42, Positron Emission Tomography (PET), Protocols, Public Health Epidemiology and Biostatistics: Birmingham, Queen's University (Canada), Radcliffe Department of Medicine, ratio, rCBF SPECT, Research Protocol, School for Mental Health and Neuroscience: Maastricht University, Shengjing Hospital, sMRI (Structural Magnetic Resonance Imaging), SPECT (Single Photon Emission Computed Tomography), St Louis University Mental Status Examination (SLUMS), Study Protocol, Sunnybrook Health Sciences Centre (Toronto), Systematic Reviews and Meta-Analyses, Test Your Memory (TYM), University Hospitals Bristol, University of Birmingham, University of Bristol, University of Cambridge, University of Exeter, University of Exeter Medical School, University of Glasgow, University of Milan, University of Oxford, University of Toronto, VU University (Netherlands), VU University Medical Centre
|
Leave a comment
Low Dose Aspirin for the Over-Fifties? (BBC News / Annals of Oncology)
Summary Analysis of roughly 200 studies investigating the benefits and harms of taking aspirin indicates that a small dose of aspirin every day could help to prevent deaths from bowel, stomach and oesophageal cancers. Approximately 122,000 deaths could be prevented … Continue reading →
Posted in BBC News, For Doctors (mostly), For Nurses and Therapists (mostly), For Researchers (mostly), In the News, International, Pharmacological Treatments, Practical Advice, Quick Insights, Statistics, Stroke, Systematic Reviews, UK, Universal Interest
|
Tagged American Cancer Society, Annals of Oncology, Aspirin, Aspirin: Low-Dose Acetylsalicylic Acid, Avoidable Mortality, Avoidable Premature Mortality, BBC Health News, Blizard Institute of Cell and Molecular Science: Queen Mary University of London, Brigham and Women's Hospital, Brigham and Women's Hospital and Harvard Medical School, Cancer, Cardiovascular Disease, Chao Family Comprehensive Cancer Center: University of California, CVD: Cardiovascular Disease, Daily Low-Dose Aspirin, Department of Epidemiology: American Cancer Society, Epidemiology, Epidemiology and Statistics, Epidemiology Research Program: American Cancer Society, Gastrointestinal and Other Cancers Research Group: National Cancer Institute, Gastrointestinal Bleeding, Harvard Medical School, IRCCS-Istituto di Ricerche Farmacologiche ‘Mario Negri’ (Milan), National Cancer Institute: National Institutes of Health, National Institutes of Health (NIH), National Institutes of Health (US), Newcastle University, Nuffield Department of Clinical Neuroscience: University of Oxford, Peninsula Schools of Medicine and Dentistry: Plymouth University, Plymouth University, Prophylactic Use of Aspirin, Queen Mary University, Queen Mary University of London, Stroke and Bleeding Risk Stratification, Stroke Prevention Research Unit: University of Oxford, Systematic Reviews and Meta-Analyses, Tumor and Breast Center ZeTuP (Switzerland), University of California, University of Milan, University of Oxford, University of Texas MD Anderson Cancer Center, Wolfson Institute of Preventive Medicine: Queen Mary University of London
|
Leave a comment
